Ilia I. Ouspenski

Array ( [id] => 5452166 [patent_doc_number] => 20090068203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Methods for treating cardiovascular disease using a soluble CTLA4 Molecule' [patent_app_type] => utility [patent_app_number] => 11/892000 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 103 [patent_no_of_words] => 51233 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068203.pdf [firstpage_image] =>[orig_patent_app_number] => 11892000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385173 [patent_doc_number] => 20090226417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Human B7 polypeptides' [patent_app_type] => utility [patent_app_number] => 11/890871 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226417.pdf [firstpage_image] =>[orig_patent_app_number] => 11890871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915174 [patent_doc_number] => 20080095774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Agents and Methods for Specifically Blocking CD28-Mediated Signaling' [patent_app_type] => utility [patent_app_number] => 11/831517 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 36702 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095774.pdf [firstpage_image] =>[orig_patent_app_number] => 11831517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720316 [patent_doc_number] => 20080242839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'HUMAN CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/782545 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61391 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242839.pdf [firstpage_image] =>[orig_patent_app_number] => 11782545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121173 [patent_doc_number] => 07709214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1' [patent_app_type] => utility [patent_app_number] => 11/765838 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 53240 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709214.pdf [firstpage_image] =>[orig_patent_app_number] => 11765838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595489 [patent_doc_number] => 20100062473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'IMMUNITY EVALUATION METHOD, IMMUNITY EVALUATION APPARATUS, IMMUNITY EVALUATION PROGRAM AND DATA RECORDING MEDIUM HAVING THE IMMUNITY EVALUATION PROGRAM STORED THEREIN' [patent_app_type] => utility [patent_app_number] => 12/304825 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14720 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062473.pdf [firstpage_image] =>[orig_patent_app_number] => 12304825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740816 [patent_doc_number] => 20080234469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'TUMOUR NECROSIS FACTOR BINDING LIGANDS' [patent_app_type] => utility [patent_app_number] => 11/761228 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 13410 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234469.pdf [firstpage_image] =>[orig_patent_app_number] => 11761228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575439 [patent_doc_number] => 20090142801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'BTL-II NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 11/760515 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 30782 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142801.pdf [firstpage_image] =>[orig_patent_app_number] => 11760515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165590 [patent_doc_number] => 20070287177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'TUMOUR NECROSIS FACTOR BINDING LIGANDS' [patent_app_type] => utility [patent_app_number] => 11/759787 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 13410 [patent_no_of_claims] => 202 [patent_no_of_ind_claims] => 50 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287177.pdf [firstpage_image] =>[orig_patent_app_number] => 11759787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 215110 [patent_doc_number] => 07618628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'CD16A binding proteins and use for the treatment of immune disorders' [patent_app_type] => utility [patent_app_number] => 11/757932 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 22588 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618628.pdf [firstpage_image] =>[orig_patent_app_number] => 11757932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10586663 [patent_doc_number] => 09308259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance' [patent_app_type] => utility [patent_app_number] => 12/303648 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2249 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575825 [patent_doc_number] => 07452536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Methods of treating cancer by administering antibodies to CD200' [patent_app_type] => utility [patent_app_number] => 11/753908 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 37682 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452536.pdf [firstpage_image] =>[orig_patent_app_number] => 11753908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872732 [patent_doc_number] => 20080199466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'HUMAN MONOCLONAL ANTIBODY AGAINST A COSTIMULATORY SIGNAL TRANSDUCTION MOLECULE AILIM AND PHARMACEUTICAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/752659 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 47775 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11752659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311087 [patent_doc_number] => 07528111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Method of vaccinating subjects receiving immune modulating therapy' [patent_app_type] => utility [patent_app_number] => 11/800860 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528111.pdf [firstpage_image] =>[orig_patent_app_number] => 11800860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772598 [patent_doc_number] => 20080058257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Costimulatory Molecules and Uses thereof' [patent_app_type] => utility [patent_app_number] => 11/741133 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9838 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058257.pdf [firstpage_image] =>[orig_patent_app_number] => 11741133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311212 [patent_doc_number] => 07528237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/737608 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 41 [patent_no_of_words] => 15616 [patent_no_of_claims] => 158 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528237.pdf [firstpage_image] =>[orig_patent_app_number] => 11737608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113527 [patent_doc_number] => 20070197443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Methods and Compositions for Modulating Immunity' [patent_app_type] => utility [patent_app_number] => 11/736632 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 46144 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197443.pdf [firstpage_image] =>[orig_patent_app_number] => 11736632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177522 [patent_doc_number] => 07655229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Anti-FC-gamma RIIB receptor antibody and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/787713 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 83 [patent_no_of_words] => 41793 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655229.pdf [firstpage_image] =>[orig_patent_app_number] => 11787713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246951 [patent_doc_number] => 20070243185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Polypeptide formulation' [patent_app_type] => utility [patent_app_number] => 11/784538 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7767 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243185.pdf [firstpage_image] =>[orig_patent_app_number] => 11784538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12112979 [patent_doc_number] => 09868961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Methods and compositions for localized secretion of anti-CTLA-4 antibodies' [patent_app_type] => utility [patent_app_number] => 12/294889 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10917 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294889 [rel_patent_id] =>[rel_patent_doc_number] =>)